Electrophoretic Mobility Shift Assay (EMSA) Standard Operating Procedure (SOP)

I. Overview and Principle

1.1 Basic principle of EMSA

The electrophoretic mobility shift assay (EMSA), also known as the gel shift assay, is a classic in vitro technique used to detect DNA–protein or RNA–protein interactions under non-denaturing polyacrylamide gel electrophoresis (native PAGE) conditions.

Under non-denaturing conditions:

(1) A free nucleic acid probe migrates downward as a single band.

(2) When the nucleic acid binds a protein to form a complex, the overall molecular mass and conformation change, resulting in slower migration and an upward-shifted “shift” band on the gel.

(3) When a specific antibody that recognizes the target protein is added to the binding reaction, a nucleic acid–protein–antibody ternary complex may form. Its mobility is further reduced, producing a “supershift” band, which helps confirm the identity of the binding protein.

1.2 Main applications

(1) Studying interactions between DNA-binding proteins and specific DNA sequences (promoters, enhancers, motifs, etc.).

(2) Comparing binding capacities using mutant probes or under different stimulation conditions to dissect transcriptional regulation and signaling pathways.

(3) Qualitative or semi-quantitative analysis of DNA–protein or RNA–protein binding to evaluate affinity and/or competition.

(4) With supershift and mass spectrometry, preliminarily identifying key protein components in the complex.

1.3 Methodological strengths and limitations

(1) Strengths

1. High sensitivity: radiolabeled probes or highly sensitive non-radioactive probes enable detection at low protein and nucleic acid concentrations.
2. Broad applicability: compatible with DNA/RNA of various lengths and structures, and with proteins ranging from small peptides to large transcriptional complexes.
3. Tunable conditions: buffer composition, salt concentration, pH, and temperature can be optimized over a broad range; the method is robust and amenable to standardization.

(2) Limitations

1. Limited structural resolution: EMSA does not directly identify specific amino acid contacts or precise interfaces; complementary structural biology methods are needed.
2. Attribution challenges with complex samples: cell or tissue extracts contain many nucleic acid-binding proteins; supershift, mass spectrometry, ChIP, and other methods are often required to identify the responsible protein(s).
3. Mobility is multifactorial: gel percentage, electrophoresis conditions, nucleic acid length/sequence, and complex charge/conformation can all affect migration; proper controls are essential for interpretation.

II. Sample and Reagent Preparation

2.1 Sample types and recommended amounts

(1) Recombinant protein

1. Recommended total recombinant protein per gel: ≥50 μg.
2. Exchange into, or dissolve the protein in, an EMSA-compatible native (non-denaturing) protein buffer, ensuring that no denaturants are present.
3. Recommended final concentration: ≥0.2 mg/mL.

(2) Cell samples

1. Approximately 1×10⁷ cells or one 10 cm dish (80–90% confluence).
2. Prepare total protein or nuclear extracts as needed; add protease inhibitors; keep at 4°C or on ice throughout.

(3) Animal tissue samples

Fresh tissue ≥0.2 g; process immediately at low temperature after collection to reduce proteolysis.

(4) Plant tissue samples

Fresh young tissue ≥0.5 g; typically ground to powder in liquid nitrogen prior to protein extraction.

(5) Supershift antibody

Target-protein-specific IP-grade antibody for supershift; volume ≥10 μL; must be validated to recognize the native conformation.

(6) General requirements

1. Total protein, nuclear protein, or purified protein may be used; add equal protein amounts to all experimental groups.
2. Recommended protein concentration: ≥100 ng/μL.
3. Avoid repeated freeze–thaw cycles; aliquot and store at −80°C; keep working aliquots at 4°C for short-term use.

2.2 Key reagents and buffers

(1) Non-denaturing PAGE components

1. Acrylamide/bis-acrylamide stock solution.
2. Tris buffers suitable for separating gel and stacking gel.
3. APS solution and TEMED.
4. 0.5× TBE running buffer.

(2) Binding reaction components (optimize as required)

1. 10× binding buffer: typically contains Tris-HCl (pH 7.5–8.0), KCl or NaCl, MgCl₂, DTT, glycerol, etc.
2. Non-specific competitor nucleic acids: e.g., poly(dI–dC) or salmon sperm DNA, to suppress non-specific binding.
3. Labeled probe: radiolabeled, biotin-labeled, or fluorescently labeled oligonucleotides.
4. Cold competitor probe: unlabeled oligonucleotide of the same sequence.
5. Specific antibody: for supershift reactions.

(3) Blotting and detection components (example: biotin-labeled probe)

1. Positively charged nylon membrane.
2. Streptavidin–HRP or other appropriate chromogenic/ chemiluminescent reagents.
3. Chemiluminescent substrate or corresponding detection system.

2.3 Instruments and consumables

(1) Gel casting system and combs (recommended thickness: 1.0 mm).

(2) Vertical electrophoresis tank and constant-voltage power supply.

(3) 37°C incubator (to promote gel polymerization).

(4) Blotting apparatus (wet transfer or semi-dry transfer).

(5) UV crosslinker (if nucleic acid crosslinking on the membrane is needed).

(6) Chemiluminescence or fluorescence imaging system.

(7) RNase/DNase-free tips, microcentrifuge tubes, and low protein-binding consumables.

III. Experimental Procedure

3.1 Preparation of non-denaturing PAGE gel

(1) Cleaning and assembly

1. Thoroughly clean gel plates, spacers, and combs to ensure no residual denaturants (e.g., SDS, DTT).
2. Assemble the plates according to the manufacturer’s instructions and confirm a proper seal to prevent leakage.

(2) Gel preparation and casting

1. Select the acrylamide percentage based on expected resolution (commonly 4–8%).
2. Mix acrylamide solution, Tris buffer, and distilled water at the desired ratio.
3. Immediately before pouring, add APS and TEMED in sequence; mix and pour promptly, avoiding bubbles.
4. Insert the comb and allow to polymerize at 37°C for ~1 h until fully set.

3.2 Assembly of the binding reaction

At minimum, set up the following groups:

(1) Negative control: probe + binding buffer + non-specific DNA, without protein, to indicate the free-probe position.

(2) Positive control: probe + a known binding protein, to validate assay functionality.

(3) Experimental group: probe + test protein.

(4) Cold competition group: experimental group + excess unlabeled same-sequence probe, to confirm sequence specificity.

(5) Supershift group: experimental group + target-specific antibody, to assess supershift.

Recommended order of addition:

1. Nuclease-free water or low-salt buffer.
2. 10× binding buffer.
3. Non-specific competitor DNA.
4. Protein sample; mix gently.
5. Add labeled probe after pre-incubation.

A typical total reaction volume is 10–20 μL, adjustable based on protein concentration and probe signal intensity.

3.3 Incubation

(1) Pre-incubation

Before adding the labeled probe, mix protein, binding buffer, and non-specific DNA; incubate at room temperature for ~10 min to reduce non-specific binding or allow cold competitors to occupy sites first.

(2) Binding with labeled probe

After adding the labeled probe, mix gently and incubate at ~25°C for ~50 min to approach binding equilibrium.

(3) Supershift reaction

For supershift assays, add the specific antibody either before or after probe addition (depending on whether the antibody affects initial binding), then incubate an additional 10–30 min.

3.4 Electrophoresis

(1) Pre-run

1. Mount the polymerized gel in the electrophoresis tank and add 0.5× TBE to fully cover the gel plates.
2. Pre-run at 80 V for ~10 min to equilibrate the gel with running buffer.

(2) Sample loading

1. Remove the comb and rinse wells with 0.5× TBE.
2. Add EMSA loading buffer to each reaction and mix gently.
3. Load samples slowly to avoid damaging wells or causing overflow.

(3) Separation run

1. Run at constant 80 V.
2. Monitor gel temperature; recommended not to exceed 30°C.
3. Stop electrophoresis when bromophenol blue reaches approximately one-quarter from the bottom edge of the gel.

3.5 Transfer and detection (example: biotin-labeled probe)

(1) Transfer

1. Pre-treat a positively charged nylon membrane as required.
2. When assembling the transfer stack, remove all bubbles.
3. Transfer the complexes under appropriate current and time conditions.

(2) Fixation and blocking

1. If needed, crosslink nucleic acids on the membrane using a UV crosslinker.
2. Block the membrane at room temperature for 30–60 min to reduce non-specific binding.

(3) Detection

1. Incubate with streptavidin–HRP or the corresponding detection reagent.
2. Wash thoroughly to remove unbound conjugate.
3. Add chemiluminescent substrate and image using an appropriate system.

IV. Interpretation and Data Analysis

4.1 Band patterns

(1) Free probe band

In the negative control lane, a fast-migrating sharp band at the lower portion of the gel represents unbound probe.

(2) Shift band

In experimental lanes, a slower-migrating band above the free probe indicates a DNA–protein or RNA–protein complex. Band intensity correlates with binding amount.

(3) Supershift band

In supershift lanes containing a specific antibody, an additional band migrates even more slowly (higher on the gel), often accompanied by weakening or disappearance of the original shift band. This supports that the recognized protein is a component of the complex.

4.2 Specificity assessment

(1) Cold competition

1. If an excess unlabeled same-sequence probe markedly reduces or eliminates the shift band and increases free probe signal, binding is sequence-specific.
2. If an unrelated cold probe does not affect the shift band, this further supports specificity.

(2) Supershift confirmation

A supershift band, together with cold competition behavior, provides strong support for target-protein participation in complex formation.

4.3 Semi-quantitative evaluation

By titrating protein or probe amounts and comparing shift-band intensity/position, trends in binding capacity can be assessed. Under well-standardized conditions, relative affinity changes or approximate Kd order-of-magnitude can be estimated.

V. Common Issues and Notes

5.1 No obvious shift band

(1) Protein-related factors

1. Evaluate protein integrity and expression level by SDS-PAGE or Western blot.
2. Ensure extraction is performed at low temperature with protease inhibitors to prevent degradation.

(2) Probe-related factors

1. Assess probe integrity and labeling efficiency by PAGE.
2. Increase probe amount or switch labeling strategies if necessary.

(3) Reaction conditions

1. Moderately reduce salt concentration, adjust pH, or extend incubation time.
2. Increase protein input or reduce total reaction volume to raise effective concentration.

5.2 High background or band smearing/tailing

(1) Increase the amount of non-specific competitor DNA to suppress non-specific binding.

(2) Optimize salt concentration and glycerol content in the binding buffer to reduce non-specific electrostatic interactions.

(3) Remove endogenous nucleic acids and other interfering components from protein samples as much as feasible.

5.3 Poor resolution or diffuse bands

(1) Increase acrylamide percentage or extend electrophoresis time as appropriate.

(2) Control gel temperature; overheating promotes band diffusion.

(3) Avoid overloading, especially with complex samples.

5.4 Supershift failure

(1) Confirm the antibody recognizes the target protein in its native conformation.

(2) Optimize antibody amount and order of addition; antibody excess can destabilize complexes or promote aggregation.

(3) If supershift remains unobtainable, consider that the protein binds as part of a larger complex or that the epitope is masked. Switch antibodies or use complementary methods (e.g., ChIP, co-immunoprecipitation (Co-IP)) for validation.

Aladdin: https://www.aladdinsci.com/